Do you suffer from heart rhythm abnormalities?
You may be a candidate for S-ICD.
Delray Medical Center is the first hospital in South Florida to offer a new option to patients with heart rhythm abnormalities — the revolutionary subcutaneous ICD, an implantable defibrillator recently approved by the FDA. Implanted just under the skin, there’s less chance of infection and it may help you resume an active lifestyle.
S-ICD: subcutaneous implantable cardioverter-defibrillator
A new, less invasive heart defibrillator recently approved by the FDA is now an option for patients at Delray Medical Center who may be at risk for sudden cardiac arrest. Heralded as a breakthrough treatment by many cardiologists today, the device is known as S-ICD, which stands for subcutaneous implantable cardioverter-defibrillator.
Sudden cardiac arrest (SCA)
is an abrupt loss of heart function. Most episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular
tachycardia or ventricular fibrillation.
The S-ICD system is designed to provide the same protection from SCA as traditional transvenous implantable cardioverter defibrillators (ICDs). However, the entirety of the S-ICD system sits just below the skin without the need for thin, insulated wires — known as leads — to be placed into the heart itself. This leaves the heart and blood vessels untouched, providing a new exciting solution for both physicians and patients.
The S-ICD has two main components:
the pulse generator, which powers the system, monitors heart activity, and delivers a shock if needed
- the electrode, which enables the device to sense the cardiac rhythm and serves as a pathway for shock delivery when necessary
Both components are implanted just under the skin — the generator at the side of the chest, and the electrode beside the breastbone.
To learn more about Delray Medical Center’s Heart Rhythm Device Management Program, call 888-7-DELRAY.